Cytosorbents Corporation
CTSO
$0.93
$0.02372.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.63% | 34.60% | -76.79% | -31.99% | -35.68% |
| Total Receivables | -1.02% | 13.38% | 20.84% | 7.35% | 11.36% |
| Inventory | -14.06% | -19.27% | -19.04% | 9.09% | 110.99% |
| Prepaid Expenses | -1.99% | 256.28% | 78.29% | -40.90% | -4.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.70% | 27.11% | -14.94% | -13.83% | -7.14% |
|
|
|||||
| Total Current Assets | 4.70% | 27.11% | -14.94% | -13.83% | -7.14% |
| Net Property, Plant & Equipment | -7.19% | -7.30% | -7.24% | -6.93% | -7.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -4.06% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -84.65% | -70.90% | -1.91% | 76.23% | 71.96% |
| Total Assets | -10.18% | 7.88% | -10.55% | 0.48% | 1.87% |
|
|
|||||
| Total Accounts Payable | 11.39% | 38.59% | -12.16% | -32.06% | 7.44% |
| Total Accrued Expenses | -17.42% | -31.96% | -4.82% | -18.98% | 0.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.12% | -83.62% | -84.25% | -54.55% | 260.23% |
| Total Finance Division Other Current Liabilities | 3.69% | -6.66% | -45.84% | -48.56% | -30.27% |
| Total Other Current Liabilities | 3.69% | -6.66% | -45.84% | -48.56% | -30.27% |
| Total Current Liabilities | -4.78% | -27.47% | -30.01% | -29.59% | -0.14% |
|
|
|||||
| Total Current Liabilities | -4.78% | -27.47% | -30.01% | -29.59% | -0.14% |
| Long-Term Debt | 5.15% | 635.60% | 450.41% | 228.81% | 172.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.91% | -3.71% | -3.51% | -2.51% | -2.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.78% | 28.77% | 23.03% | 19.76% | 29.42% |
|
|
|||||
| Common Stock & APIC | 3.74% | 4.08% | 1.51% | 5.58% | 5.97% |
| Retained Earnings | -3.60% | -5.75% | -7.31% | -6.75% | -9.54% |
| Treasury Stock & Other | -282.17% | -13.51% | 703.33% | -105.26% | 63.65% |
| Total Common Equity | -30.77% | -23.17% | -52.70% | -29.78% | -30.54% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.77% | -23.17% | -52.70% | -29.78% | -30.54% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.77% | -23.17% | -52.70% | -29.78% | -30.54% |
|
|
|||||